Chlamydia trachomatis IgM is a blood test that detects IgM antibodies produced by the immune system in response to Chlamydia trachomatis exposure. IgM antibodies may appear relatively early during an immune response and can provide supportive information about recent exposure or infection. The test may be used in selected clinical situations, but IgM results alone cannot reliably confirm an active chlamydial infection and should be interpreted with other diagnostic findings.
A positive result indicates that IgM antibodies were detected. It may suggest recent exposure, but the result alone cannot reliably establish an active Chlamydia trachomatis infection.
A negative result means detectable IgM antibodies were not found. However, it does not completely exclude current infection, particularly when testing is performed early or when antibody testing is not appropriate for the infection site.
No. Although IgM can appear relatively early in an immune response, the test cannot reliably determine the exact timing of infection or exposure.
Antibody responses may persist after an infection has been treated. Therefore, a positive IgM result should not automatically be interpreted as evidence of ongoing infection.
No. IgM testing detects antibodies produced by the immune system, while PCR and other nucleic acid amplification tests detect genetic material from the organism and are generally preferred for identifying active infection.
OTP sent to your mobile number on whatsapp
Didn't recieved OTP Yet? Resend OTP
